NEW YORK (GenomeWeb) – Quest Diagnostics today reported a 2 percent year-over year increase in its revenues for the first quarter, while its diagnostic information services business grew 3 percent.

For the three months ended March 31, Quest recorded total revenues of $1.90 billion, up from $1.86 billion in the year-ago quarter and above the consensus Wall Street estimate of $1.87 billion.

Its diagnostics information services revenues grew to $1.81 billion from $1.76 billion a year ago.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Penn State Hershey Medical Center staffer has admitted to lying about skipping mandatory steps of genetic cancer tests he performed, the Associated Press reports.

The genome of a rare, red bat suggests that its effective population size has been in decline for thousands of years, according to a PLOS One study.

In Nature this week: investigation into the genetics of medulloblastoma, and more.

A project in the UK is to use genomic selection to speed spruce tree growth, according to Innovators Magazine.